227 related articles for article (PubMed ID: 36504552)
1. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number.
Hu XS; Yang HY; Leng C; Zhang ZW
World J Gastroenterol; 2022 Nov; 28(44):6271-6281. PubMed ID: 36504552
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
[TBL] [Abstract][Full Text] [Related]
4. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
5. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
7. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract][Full Text] [Related]
8. Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System.
Wee IJY; Moe FNN; Sultana R; Ang RWT; Quek PPS; Goh BKP; Chan CY; Cheow PC; Chung AYF; Jeyaraj PR; Koh YX; Mack POP; Ooi LLPJ; Tan EK; Teo JY; Kam JH; Chua JSS; Ng AWY; Goh JSQ; Chow PKH
J Hepatocell Carcinoma; 2022; 9():839-851. PubMed ID: 35999856
[TBL] [Abstract][Full Text] [Related]
9. Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological outcomes.
Martin D; Smet H; Da Silva Costa AC; Halkic N; Uldry E; Tabrizian P; Schwartz M; Mahamid A; Goumard C; Scatton O; Perinel J; Adham M; Demartines N; Melloul E
HPB (Oxford); 2023 Jul; 25(7):836-844. PubMed ID: 37098458
[TBL] [Abstract][Full Text] [Related]
10. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
Tian Y; Lyu H; He Y; Kanduri HK
J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
[TBL] [Abstract][Full Text] [Related]
12. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
13. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
[TBL] [Abstract][Full Text] [Related]
14. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
[TBL] [Abstract][Full Text] [Related]
15. Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).
Bell R; Pandanaboyana S; Lodge JPA; Prasad KR; Jones R; Hidalgo E
Langenbecks Arch Surg; 2017 Jun; 402(4):575-583. PubMed ID: 27456677
[TBL] [Abstract][Full Text] [Related]
16. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
19. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
